Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric H Kim

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
BJUI Compass|August 28, 2023
Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imagingRicardo de Almeida S, Jamie Thomas, Matthew M Mason, et al.
Molecular Cancer Research : MCR|October 17, 2024
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic PhenotypeJoseph E Ippolito, Jordan P Hartig, Kaitlyn Bejar, et al.
Plos Medicine|December 14, 2021
Correction: Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort studyPradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, et al.
Plos Medicine|August 31, 2021
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort studyPradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, et al.
NPJ Precision Oncology|January 19, 2023
Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patientsPradeep S Chauhan, Alexander Shiang, Irfan Alahi, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|June 15, 2023
Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's GuideAnup S Shetty, Tyler J Fraum, David H Ballard, et al.
Clinical and Translational Radiation Oncology|January 19, 2019
A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer DatabaseBenjamin W Fischer-Valuck, Jeff M Michalski, Jessika A Contreras, et al.
Clinical Genitourinary Cancer|November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent ChemoradiotherapyBenjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.
JCO Precision Oncology|July 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective StudyJohn Nikitas, Kritika Subramanian, Nimrod Barashi Gozal, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
BJUI Compass|August 28, 2023
Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imagingRicardo de Almeida S, Jamie Thomas, Matthew M Mason, et al.
Molecular Cancer Research : MCR|October 17, 2024
N-Linked Fucosylated Glycans Are Biomarkers for Prostate Cancer with a Neuroendocrine and Metastatic PhenotypeJoseph E Ippolito, Jordan P Hartig, Kaitlyn Bejar, et al.
Plos Medicine|December 14, 2021
Correction: Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort studyPradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, et al.
Plos Medicine|August 31, 2021
Urine tumor DNA detection of minimal residual disease in muscle-invasive bladder cancer treated with curative-intent radical cystectomy: A cohort studyPradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, et al.
NPJ Precision Oncology|January 19, 2023
Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patientsPradeep S Chauhan, Alexander Shiang, Irfan Alahi, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|June 15, 2023
Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User's GuideAnup S Shetty, Tyler J Fraum, David H Ballard, et al.
Clinical and Translational Radiation Oncology|January 19, 2019
A propensity analysis comparing definitive chemo-radiotherapy for muscle-invasive squamous cell carcinoma of the bladder vs. urothelial carcinoma of the bladder using the National Cancer DatabaseBenjamin W Fischer-Valuck, Jeff M Michalski, Jessika A Contreras, et al.
Clinical Genitourinary Cancer|November 14, 2020
Management of Muscle-Invasive Bladder Cancer During a Pandemic: Impact of Treatment Delay on Survival Outcomes for Patients Treated With Definitive Concurrent ChemoradiotherapyBenjamin W Fischer-Valuck, Jeff M Michalski, Joanna G Harton, et al.
JCO Precision Oncology|July 16, 2024
Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective StudyJohn Nikitas, Kritika Subramanian, Nimrod Barashi Gozal, et al.
Journal of the National Cancer Institute|September 26, 2025
Assessing the oncologic risk when systematic and multiparametric magnetic resonance imaging-targeted prostate biopsy grade groups are discordantSimone Scuderi, , Amy L Tin, et al.
Pageof 13